Skip to main content

Cellulitis and Skin and Soft Tissue Infections

A red, warm, tender leg is one of the most common reasons patients come to clinics and emergency departments — and one of the most commonly mishandled. Most of the time it is cellulitis, a bacterial infection of the deeper skin that a short antibiotic course will cure. But hidden among these everyday cases are two traps: red legs that are not infected at all (and get needless antibiotics), and a small number that are life-threatening necrotizing infections requiring the operating theatre within hours. Learning to tell these apart is a genuinely high-stakes clinical skill.

This page teaches skin and soft tissue infections (SSTIs) the way a clinician reasons through them at the bedside: what layer is infected, whether there is pus to drain, which organisms are likely, when to worry, and how to choose treatment without either under-treating a spreading infection or over-treating a harmless mimic.

Learning Objectives​

  • Distinguish the layers and named entities of SSTI: impetigo, erysipelas, cellulitis, abscess, and necrotizing fasciitis.
  • Apply the purulent versus non-purulent framework that drives antibiotic choice.
  • Identify the likely organisms (Streptococcus pyogenes, Staphylococcus aureus, including MRSA) and their coverage.
  • Recognize the red flags of necrotizing infection and act on them urgently.
  • List the common mimics of cellulitis and avoid unnecessary antibiotics.
  • Outline outpatient versus inpatient management and prevention of recurrence.

Quick Answer​

Skin and soft tissue infections are graded by depth. Impetigo is superficial; erysipelas involves the upper dermis with sharp raised borders; cellulitis extends into the deeper dermis and subcutaneous fat with poorly defined edges; necrotizing fasciitis destroys the fascial planes and is a surgical emergency. The key bedside decision is purulent versus non-purulent. Non-purulent cellulitis is usually streptococcal and treated with a beta-lactam. Purulent infection (an abscess or pus) is usually staphylococcal, may be MRSA, and the priority is drainage — incision and drainage often matters more than the antibiotic. Warning signs of a necrotizing infection are pain out of proportion to the exam, rapid spread, systemic toxicity, skin necrosis or bullae, and crepitus; these demand immediate surgical assessment. Finally, many "red legs" are not infected: bilateral redness, chronic venous change, or a swollen calf may be stasis dermatitis or DVT, not cellulitis.

Where It Came From​

Skin infections are as old as humanity, but our understanding sharpened with the germ theory revolution of the late nineteenth century. Erysipelas — from the Greek for "red skin" — was a feared, sometimes epidemic hospital infection long before its cause was known; the sharply demarcated, advancing red plaque was so recognizable that physicians described it for centuries. In the 1880s, as Louis Pasteur and Robert Koch established that specific microbes cause specific diseases, Friedrich Fehleisen identified streptococci in erysipelas lesions, tying a classic clinical picture to a named organism.

The need that drove this field forward was mortality. Before antibiotics, erysipelas and its deeper cousins could progress to fatal bloodstream infection, and necrotizing "hospital gangrene" carried a grim prognosis during wartime and in crowded surgical wards. The arrival of penicillin in the 1940s transformed streptococcal skin infection from a potential killer into a treatable illness, and this remains why simple cellulitis is now rarely fatal.

The modern chapter is resistance. From the late 1990s a new strain, community-associated MRSA (methicillin-resistant Staphylococcus aureus), spread among otherwise healthy people, causing recurrent skin abscesses that no longer responded to the usual beta-lactams. This shifted practice: clinicians now routinely ask whether an infection is purulent — a proxy for likely staph and possible MRSA — before choosing a drug. The whole purulent-versus-non-purulent framework exists because the organisms, and their resistance, differ.

Anatomy of Infection: Which Layer, Which Disease​

SSTIs are best understood as a ladder from superficial to deep, because depth predicts both severity and the likely organism.

Impetigo is a superficial infection of the epidermis, common in children, producing honey-coloured crusts. It is caused by Staphylococcus aureus and Streptococcus pyogenes and treated topically or with a short oral course.

Erysipelas involves the upper dermis and superficial lymphatics. Its hallmark is a bright red, raised plaque with a sharply demarcated, palpable border — you can feel where infected meets normal skin — often on the face or shins, frequently with fever. It is almost always streptococcal.

Cellulitis extends deeper, into the lower dermis and subcutaneous fat. The redness is more diffuse with indistinct, sloping borders, warm and tender, typically on a lower limb. Compared with erysipelas it is flatter and less sharply edged. The dominant organisms are beta-hemolytic streptococci (especially S. pyogenes) and S. aureus.

Abscess is a walled-off collection of pus in the dermis or subcutaneous tissue — a tender, fluctuant lump, usually staphylococcal. The defining feature is that it contains drainable pus.

Necrotizing fasciitis is the emergency at the bottom of the ladder: infection tracks along the fascia beneath the fat, causing tissue death and systemic toxicity. It can be polymicrobial (type 1) or driven by group A Streptococcus, sometimes with S. aureus (type 2). It is uncommon but must never be missed.

The Central Decision: Purulent versus Non-Purulent​

Modern guidelines pivot on a single question at the bedside: is there pus?

Non-purulent cellulitis — spreading redness, warmth, and tenderness with no abscess or drainable pus — is predominantly streptococcal. Streptococci remain reliably sensitive to beta-lactams, so first-line therapy targets them: for example oral cephalexin or dicloxacillin, or intravenous cefazolin if the patient is unwell. Routine MRSA coverage is not needed for simple non-purulent cellulitis.

Purulent infection — an abscess, a furuncle, or frank pus — is predominantly staphylococcal and may be MRSA. Here the single most important intervention is incision and drainage (I&D). For a simple, small abscess in a well patient, drainage alone may suffice; antibiotics are added for larger lesions, surrounding cellulitis, systemic signs, or immunocompromise, and should then cover MRSA (for example trimethoprim-sulfamethoxazole, doxycycline, or clindamycin orally; vancomycin or linezolid intravenously).

Worked Example: Choosing Therapy​

A healthy 40-year-old presents with 2 days of a warm, red, tender, ill-defined patch spreading up the shin. There is no fluctuance, no abscess, and no pus. She is afebrile and well.

  • Classify: Non-purulent cellulitis, likely streptococcal.
  • Assess severity: Systemically well, no red flags, tolerating oral intake — suitable for outpatient oral therapy.
  • Treat: Oral cephalexin, with the leg elevated. Mark the border of the redness with a pen and date it so progression can be judged objectively.
  • Safety-net: Return if the redness crosses the mark despite treatment, if fever develops, if pain becomes severe, or if any blistering or dusky skin appears.

Contrast this with a patient who has a fluctuant, pus-filled lump: there the answer starts with drainage, and MRSA-active antibiotics are added only if there is surrounding cellulitis or systemic illness.

The Emergency You Cannot Miss: Necrotizing Fasciitis​

Necrotizing fasciitis is rare but rapidly fatal if treatment is delayed, and early it can masquerade as ordinary cellulitis. The features that should raise alarm:

  • Pain out of proportion to the visible skin findings — often the earliest and most important clue.
  • Rapid progression over hours, sometimes with a spreading marked border outrunning any antibiotic.
  • Systemic toxicity: high fever, tachycardia, hypotension, confusion.
  • Skin changes: dusky or grey discolouration, hemorrhagic bullae, or areas of anesthesia (dead nerves), and later crepitus (gas in tissues).
  • Firm, wooden induration extending beyond the visible redness.

Laboratory clues (very high white cell count, high C-reactive protein, low sodium, rising creatinine and lactate) support the diagnosis but must never delay it. The treatment is urgent surgical exploration and debridement plus broad-spectrum antibiotics (typically covering gram-positives including MRSA, gram-negatives, and anaerobes) with clindamycin added for its toxin-suppressing effect. Imaging is useful only if it does not delay surgery. The rule to remember: necrotizing fasciitis is a diagnosis made and treated in the operating theatre, not the radiology suite.

Real-World Applications​

  • Emergency and primary care triage: The purulent/non-purulent split and the red-flag list let clinicians rapidly sort the routine from the dangerous.
  • Bedside marking: Drawing and dating the border of erythema is a simple, powerful tool to distinguish treatment response from progression.
  • Recurrent cellulitis: Patients with repeated episodes benefit from addressing the entry point — treating tinea pedis (athlete's foot) between the toes, moisturizing cracked skin, managing lymphoedema and venous disease — and sometimes prophylactic penicillin.
  • Diabetic foot infection: A specialized, higher-risk SSTI where vascular disease, neuropathy, and polymicrobial infection change management and demand multidisciplinary care.

Common Mistakes​

  • Treating bilateral red legs as cellulitis. Cellulitis is almost always unilateral. Symmetric redness of both lower legs is far more often venous stasis dermatitis, which does not respond to antibiotics. Correction: reserve the cellulitis diagnosis for a unilateral, acutely spreading, tender area, and consider stasis dermatitis when both legs are chronically involved.
  • Giving antibiotics for an abscess without draining it. Antibiotics penetrate a walled-off pus collection poorly, so the infection persists. Correction: the primary treatment for an abscess is incision and drainage; antibiotics are an adjunct, not a substitute.
  • Adding MRSA coverage to every cellulitis. Simple non-purulent cellulitis is streptococcal and needs a beta-lactam, not broad anti-MRSA therapy, which drives resistance and side effects. Correction: reserve MRSA coverage for purulent infection or specific risk factors.
  • Dismissing severe pain as anxiety. Pain out of proportion to modest-looking skin is a classic early sign of necrotizing fasciitis. Correction: take disproportionate pain seriously and escalate for surgical assessment.

Comparison and Connections​

FeatureErysipelasCellulitisAbscessNecrotizing fasciitis
DepthUpper dermis, lymphaticsLower dermis, subcutaneous fatDermis/subcutis (pus cavity)Fascia and deeper
BorderSharp, raised, well-definedDiffuse, indistinctLocalized fluctuant lumpIll-defined, spreading fast
Main organismStreptococcusStrep and staphStaph (often MRSA)Polymicrobial or group A strep
PusNoNoYes (drainable)Necrotic tissue, hemorrhagic bullae
Core treatmentBeta-lactamBeta-lactam (add MRSA if purulent)Incision and drainageEmergency surgery plus broad antibiotics
Danger levelLow to moderateLow to moderateLow if drainedLife-threatening

For the drug reasoning behind these choices, see the antimicrobial content in Antimicrobial Resistance and Stewardship and drug mechanisms in Pharmacology. When an SSTI seeds the bloodstream, it connects directly to Sepsis and Septic Shock.

Practice Questions​

Recall​

Q: What is the single most useful bedside distinction that guides antibiotic choice in SSTI? A: Purulent versus non-purulent. Non-purulent cellulitis is usually streptococcal (beta-lactam); purulent infection is usually staphylococcal and may be MRSA, and the priority is drainage.

Understanding​

Q: Why does erysipelas have a sharp, raised border while cellulitis has a diffuse one? A: Erysipelas involves the upper dermis and superficial lymphatics, so the inflammation is confined and demarcated. Cellulitis extends into the deeper dermis and subcutaneous fat, where the inflammation spreads more diffusely, giving indistinct, sloping edges.

Application​

Q: A well patient has a 3 cm fluctuant, pus-filled lump with a small rim of redness and no fever. What is the first step, and when would you add antibiotics? A: Perform incision and drainage first. Add MRSA-active antibiotics if there is significant surrounding cellulitis, systemic signs, multiple lesions, immunocompromise, or failure to respond to drainage alone.

Analysis​

Q: A patient with a red leg reports pain far worse than the skin looks, is spreading over hours, and has a fever with confusion. Cellulitis was diagnosed yesterday and antibiotics were started. What is the concern and what should happen now? A: These features — pain out of proportion, rapid progression despite antibiotics, and systemic toxicity — suggest necrotizing fasciitis. This is a surgical emergency: urgent surgical exploration and debridement plus broad-spectrum antibiotics (including clindamycin for toxin suppression) are needed, and imaging must not delay surgery.

FAQ​

How do I know if a red leg is cellulitis or just a mimic? Cellulitis is typically unilateral, acute, spreading, warm, and tender, often with fever. Bilateral, chronic, symmetric redness is more likely venous stasis dermatitis; a swollen, painful calf may be a deep vein thrombosis; and a well-demarcated, itchy, recurrent plaque may be eczema or a drug reaction. When in doubt, reassess after a short interval and look for systemic signs.

Do I always need antibiotics for a skin abscess? Not always. A small, simple abscess in a healthy person may be cured by drainage alone. Antibiotics are added for larger lesions, surrounding cellulitis, systemic illness, immunocompromise, or when drainage does not resolve it.

Why does my cellulitis keep coming back? Recurrence usually reflects a persistent entry point or predisposing condition: athlete's foot cracking the skin between the toes, chronic swelling (lymphoedema), venous disease, or obesity. Treating these, and sometimes taking preventive penicillin, reduces recurrences.

Is the redness getting slightly bigger after starting antibiotics a treatment failure? Not necessarily. Redness can advance a little in the first 24 to 48 hours even as the infection responds, and inflammation may briefly worsen as bacteria are killed. This is why marking the border helps — real failure is significant progression beyond the mark plus worsening systemic signs.

Should I be scared of MRSA? MRSA is a common cause of skin abscesses but is usually treatable. It matters because it removes ordinary beta-lactams as options, so purulent infections are treated with drainage plus MRSA-active drugs. It is not a reason to panic, but a reason to drain abscesses and choose antibiotics thoughtfully.

Quick Revision​

  • SSTIs ladder by depth: impetigo (epidermis), erysipelas (upper dermis, sharp border), cellulitis (deeper dermis/fat, diffuse border), abscess (pus cavity), necrotizing fasciitis (fascia, emergency).
  • The key question is purulent versus non-purulent.
  • Non-purulent cellulitis = streptococcal = beta-lactam (cephalexin, cefazolin); no routine MRSA cover.
  • Purulent = staph, possibly MRSA = drain first, add MRSA-active antibiotics if needed.
  • Necrotizing fasciitis red flags: pain out of proportion, rapid spread, systemic toxicity, dusky skin/bullae, crepitus — go to surgery, do not wait for imaging.
  • Cellulitis is usually unilateral; bilateral red legs are often stasis dermatitis, not infection.
  • Prevent recurrence by treating the entry point (tinea pedis, cracked skin) and underlying swelling.

Prerequisites​

Next Topics​